SWAG视频

Skip to Content Skip to Footer
SWAG视频 Logo

What are you looking for?
Moses S.S. Chow, PharmD

Moses S.S. Chow, PharmD

Professor

College of Pharmacy

mchow@westernu.edu

Phone: 909-469-5301

  • Education

    AA 1968
    City College of San Francisco

    PharmD 1972
    University of California, San Francisco

    Credential

    FCCP 1985 American College of Clinical Pharmacy

    FCP 1988 American College of Clinical Pharmacology

  • Education Experience

    PGY1 Training

    Clinical Pharmacy 1973 VA Hospital, Palo Alto, CA
  • Research Interest

    Dr. Chow has had over five decades of experience in transitional research and clinical studies, focusing on pharmacotherapy and pharmacokinetics related to cardiovascular medications and anticancer treatments. His recent research endeavors are aimed at creating treatment strategies for prostate cancer, developing formulations for swift drug delivery through nasal or sublingual routes, and improving health care via AI integration. Furthermore, Dr. Chow has cultivated a robust network across Asian countries, highlighted by his 8-year tenure as Director of the Pharmacy School at the Chinese University of Hong Kong and his role as the Founding President of the Asian Association of Schools of Pharmacy.
  • Publications

    Authored/co-authored over 300 articles relating to pharmacology, pharmacokinetics, drug development and education (including 63 clinical studies and publications on 5 applied patents). Examples of publications are shown below:

    1. Chow MSS, Fan Chengde, Tran Hieu, Zhao Hong, Zhou Li. Effects of diaspirin cross-linked hemoglobin (DCLHb) during and post CPR in swine. Journal of Pharmacology and Experimental Therapeutics 2001;297(1):224-229.
    2. Yin Ophelia Q.P., Tomlinson Brian, Waye Mary M.Y., Chow Albert H.L., Chow Moses S.S. "Pharmacogenetics and Herb-drug Interactions: Experience with Ginkgo Biloba and Omeprazole". Pharmacogenetics 2004;14:841-850.
    3. Chen Xiao, Yin Ophelia Q.P., Zuo Zhong, Chow Moses S.S. "Pharmacokinetics and Modeling of Quercetin and Metabolites". Pharmaceutical Research. 2005;22:892-901.
    4. Yin Ophelia Q.P., Tomlinson Brian, Chang Qi, Poon Emily, Chow Moses S.S. "CYP2C9 but not CYP2C19 polymorphisms affect the pharmacokinetics and pharmacodynamics of glibenclamide in Chinese subjects". Clinical Pharmacology and Therapeutics 2005;78:370-377.
    5. Wang ZH, Yin O, Tomlinson B, Chow M. OCT2 polymorphisms and in-vitro renal functional consequence: studies with metformin and cimetidine. Phamracogenetics and Genomics: 2008; 18: 637-645.
    6. Wang Y, Chow MSS, Zuo Z. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil. Int J Pharmaceutics 2008; 352: 217-224
    7. Wang YF, Wang Z, Zuo Joan, Tomlinson B, Lee B, Bolger M, Chow MSS. Clinical Pharmacokinetics of Buffered Propranolol Sublingual Tablet (PromptolTM) - Application of a new "physiologically based" model to assess absorption and disposition. The AAPS Journal 2013; DOI: 10.1208/s12248-013-9479-1.
    8. Cao J, Chan WC, Chow MSS. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review). Int J Oncol. 2022;60(5):52. doi:10.3892/ijo.2022.5342
    9. Wang J, Chow SL, Chow MSS, et al. Pharmacokinetics comparison of vardenafil as administered by an intranasal spray formulation vs a 10-mg oral tablet. J Sex Med. 2023; doi:10.1093/jsxmed/qdad056
    10. Chow MSS. Impact of artificial intelligence: A perspective on human life and pharmacy practice. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2023;6(3):216-219. doi:https://doi.org/10.1002/jac5.1705